Ipingbemi A E, Erhun W O
Afr J Med Med Sci. 2015 Mar;44(1):79-87.
Diabetes and its complications remain a major health challenge in Nigeria.
To evaluate the economic cost of type 2 diabetes mellitus in a secondary healthcare facility in Ibadan, Nigeria.
The study was carried out in Oyo state general hospital Ibadan, Nigeria using two methods of data collection. A retrospective study design in which data were extracted from case files of diabetic patients using a pre-designed data form and secondly with an Open-ended, Affirmation, Reflective listening and Summaries (OARS) method. Data was analysed using frequencies mean and correlation statistical tools.
Majority of the patients (73%) earned less than $125 per month. Hypertension was the most common (98.08%) co-morbid disorder with diabetes mellitus and the most common complication noted was neuropathy (48.10%). Metformin was the most widely prescribed oral hypoglycemic agent (90.40%). The annual cost of diabetes mellitus was $20,827.37. for the 52 patients while the average annual cost of diabetes per patient was $400.52 but higher in age group 60-69 years. There was a significant correlation (p < 0.05) between age (at onset of diabetes and at registration at the healthcare facility) and total cost of drugs used.
The study demonstrated that type 2 diabetes mellitus and its complications imposed significant economic burden on the patients. There is need for the policy maker of health sector in the country to plan towards reducing the financial burden of diabetes on the society.
糖尿病及其并发症仍是尼日利亚面临的一项重大健康挑战。
评估尼日利亚伊巴丹一家二级医疗机构中2型糖尿病的经济成本。
该研究在尼日利亚伊巴丹的奥约州综合医院开展，采用两种数据收集方法。一种是回顾性研究设计，使用预先设计的数据表从糖尿病患者的病历中提取数据；另一种是采用开放式、肯定式、反思性倾听和总结（OARS）方法。使用频率、均值和相关性统计工具对数据进行分析。
大多数患者（73%）每月收入低于125美元。高血压是糖尿病最常见的（98.08%）合并症，最常见的并发症是神经病变（48.10%）。二甲双胍是最广泛使用的口服降糖药（90.40%）。52名患者的糖尿病年度成本为20,827.37美元，每位患者的糖尿病年均成本为400.52美元，但在60 - 69岁年龄组中更高。糖尿病发病年龄和在医疗机构登记时的年龄与所用药物的总成本之间存在显著相关性（p < 0.05）。
该研究表明，2型糖尿病及其并发症给患者带来了巨大的经济负担。该国卫生部门的政策制定者需要制定计划，以减轻糖尿病对社会的经济负担。
